The aim of this retrospective study was to evaluate the influence of the site of lobectomy and the presence of chronic obstructive pulmonary disease (COPD) on pulmonary function at different postoperative periods. The patients were divided into groups of COPD and non-COPD patients, and the differences between observed and predicted postoperative values of pulmonary function at different evaluation times according to the resected lobe were assessed. The observed postoperative percentage change in FEV (opo%DFEV ) -predicted COPD patients was of significantly higher positive value than in non-COPD patients. In non-COPD patients, opo%DFEV -ppo%DFEV one 1 1 month and six months after surgery was of significantly higher negative value in those who had right upper lobectomy than in those who had right lower lobectomy or left lower lobectomy (P-0.05). COPD may strongly influence pulmonary function at early-and late-terms after upper lobectomy. In non-COPD patients, the site of lobectomy may strongly influence pulmonary function at early-and late-terms after surgery.
Introduction
Pulmonary function after major lung resection plays an important role in postoperative quality of life w1, 2x. Previous studies showed that predicted values of pulmonary function after major lung resection correlate well with those observed several months after surgery w1-5x. Meanwhile, several studies have shown discordance between observed and predicted values of pulmonary function at the early-term after lobectomy w6-8x.
Furthermore, a recent study showed that the postsurgical observed values in patients who had lower lobectomy and chronic obstructive pulmonary disease (COPD) are better preserved than predicted w9-12x. The site of lobectomy w12, 13x and presence of COPD w9-12x are considered to influence postoperative pulmonary function. However, little information can be found concerning the influence of the site of lobectomy and the presence of COPD on pulmonary function at different times after lobectomy.
The aim of this study was to investigate the influence of the site of lobectomy and presence of COPD on pulmonary function at different postoperative periods. We divided our patients into COPD and non-COPD groups and retrospectively investigated pulmonary function one month and six months after lung resection according to the lobe resected. In addition, we evaluated the differences between the *Corresponding author. Tel.: q81-744-22-3051; fax: q81-744-24-8040. E-mail address: mdkeiji@m3.kcn.ne.jp (K. Kushibe).
observed and predicted postoperative values of pulmonary function.
Materials and methods
We retrospectively reviewed the medical records of 258 patients who underwent lobectomy for non-small cell lung cancer at Nara Medical University Hospital from January 2004 to June 2007. Exclusion criteria were right middle lobectomy (ns12), failure to quit smoking postoperatively (ns1), receipt of adjuvant chemotherapy or radiotherapy (ns34), and postoperative severe pulmonary complications (ns4). The total number of eligible patients was 207.
Pulmonary function tests were performed before surgery and one month and six months after surgery. Postoperative pulmonary function data were not available in 21 patients for the following reasons; four died within 30 days after surgery, four had progressive metastatic disease, and 13 were unable to be contacted one month or six months after surgery.
The final analysis included 186 patients. The patients were divided into a COPD group (ns53) and a non-COPD group (ns133) according to the Global Initiative on Obstructive Lung Disease guidelines ( Table 1) . Predicted postoperative forced expiratory volume in 1 s (FEV ) and 1 forced vital capacity (FVC) were calculated based on the number of functioningyunobstructed segments to be resected during surgery, in keeping with the British Thoracic Society recommendation w14x. The number of functioningy unobstructed segments was estimated by means of computed tomographic scan and bronchoscopy. We compared the differences between observed and predicted postoperative values of pulmonary function at different evaluation times in the COPD and non-COPD groups. As a rule, we don't need the IRB approval for the retrospective study at our institution. However, patients were fully informed about the nature of this study and all gave their informed consent for participation.
All descriptive statistics were expressed as the mean"S.D. for continuous variables. A probability value of P-0.05 was accepted as statistically significant. Statistical analysis was performed using the statistical software, Statview 5.0 (SAS Inc, Cary, NC, USA). Univariate comparison was made between the groups by means of the Student's t-test (numerical variables) and the x -test (categorical 2 variables). The Scheffé's F procedure (ANOVA test) was applied as a correction for multiple comparisons.
Results
There were 31 upper lobectomies (right upper lobectomy wRULx, ns16; left upper lobectomy wLULx, ns15), 22 lower lobectomies (right lower lobectomy wRLLx, ns11; left lower lobectomy wLLLx, ns11) in the COPD patients, and 70 upper lobectomies (RUL, ns35; LUL, ns35), 63 lower lobectomies (RLL, ns34; LLL ns29) in the non-COPD patients. The characteristics of the COPD and non-COPD patients are shown in Table 2 . Table 3 shows the percentage change in pulmonary function prior to surgery and after surgery at different evaluation times in the COPD and non-COPD patient groups. In both the COPD and non-COPD patients, all four lobectomy groups had a significant increase in the percentage change in pulmonary function six months after surgery compared with one month postoperatively (P-0.05). We compared the differences between observed and predicted postoperative values of pulmonary function at different evaluation times in the COPD and non-COPD patients ( Table 4 and six months after RUL or LUL was of a significantly higher positive value in COPD patients than in non-COPD patients (P-0.05).
When the site of lobectomy was compared in non-COPD patients, the opo%DFVC -ppo%DFVC one month after surgery in the RUL group was of a significantly higher negative value than in patients who had LUL, RLL, or LLL (P-0.05). In the non-COPD patients, the opo%DFEV -1 ppo%DFEV one month and six months after surgery was of 1 a significantly higher negative value in patients who had RUL than in those who had RLL or LLL (P-0.05).
Comments
A number of studies have demonstrated a good correlation between predicted and observed values of pulmonary function after major lung resection w1-5x. However, most of these studies assessed pulmonary function 3-6 months after surgery and several studies have shown discordance between the observed and predicted values of pulmonary function at early-term after lobectomy w6-8x. We found that all four lobectomy groups in both COPD and non-COPD patients had a significant increase in percentage change in pulmonary function six months after surgery compared with one month after surgery. A new formula is needed to predict postoperative pulmonary function at early-term after lobectomy.
Several studies have recently reported that lobectomy in select patients with lung cancer and severe COPD was favored by no change or an improvement in postoperative pulmonary function w9-12x, but little information can be found concerning the influence of COPD on pulmonary function at different times after lobectomy. Most studies assessed pulmonary function several months after lobectomy. With regard to pulmonary function at early-term after lobectomy in COPD patients, Sekine et al. showed that FEV one month after surgery was better preserved than 1 predicted w12x. Brunelli et al. showed that COPD patients had a lower percentage loss of FEV than non-COPD patients 1 one month after lobectomy w13x. We found that COPD patients had a significantly higher positive value for the opo%DFEV -ppo%DFEV one month and six months after 1 1 RUL or LUL than the non-COPD patients. These results indicate that COPD could strongly influence FEV at both 1 the early and late terms after upper lobectomy. Recent studies reported that lung volume reduction surgery (LVRS) offered a greater chance for improvement in pulmonary function in patients with predominately upper lobe emphysema compared with predominately non-upper lobe emphysema w15x. We suggested that the resection of emphysematous lung tissue in the upper lobectomy would provide the same favorable effect as LVRS in predominately upper lobe emphysema. This may explain why COPD may strongly influence FEV after upper lobectomy. in patients who had a lower lobectomy are better preserved than predicted w12x. Brunelli et al. reported that, in patients having a lower lobectomy, maximum oxygen consumption at early-term after surgery tends to be better than predicted w13x. In the non-COPD patients, we found that the opo%DFEV -ppo%DFEV one month and six months 1 1 after surgery in the RUL group had a significantly higher negative value than for those who had RLL or LLL. These results suggest that the site of lobectomy in the non-COPD patients may influence FEV strongly at both early and late 1 terms after surgery. Sekine et al. suggested that a narrowing of the orifice of the lower or middle lobe bronchus has sometimes been identified after upper lobectomy. This anatomic feature associated with upper lobectomy might make a difference in the postoperative pulmonary function compared with a lower lobectomy w12x. We speculated that, in COPD patients, upper lobectomy would have greater volume reduction effect than lower lobectomy, and would have little influence on the decrease in postoperative pulmonary function due to the anatomic feature. In contrast, in non-COPD patients, right upper lobectomy would have a strong influence on the decrease in postoperative pulmonary function due to the anatomic feature. The opo%DFVC -ppo%DFVC one month after RUL or LUL was of a significantly higher positive value in COPD patients than in non-COPD patients. In addition, we found that opo%DFVC -ppo%DFVC one month after surgery in the non-COPD patients who had RUL was of a significantly higher negative value than in those who had LUL, RLL, or LLL. We demonstrated that COPD could strongly influence FVC at early-term after upper lobectomy, and that the site of lobectomy in the non-COPD patient could influence FVC at early-term after surgery.
One question is why the site of lobectomy would influence FVC in non-COPD patients only at early-term after surgery? We suggest that the stenotic change in the residual bronchus after an upper lobectomy may slightly improve at late-term, and that the FVC would respond better to the improvement than FEV . Additionally, why would COPD 1 influence FVC only at early-term after upper lobectomy when this was not observed at late-term? Upper lobectomy would have greater volume reduction effect than lower lobectomy in COPD patients, and would have little influence on the decrease in postoperative pulmonary function due to the anatomic feature. In COPD patients, the observed FVC after upper lobectomy might be slightly better preserved than predicted. Moreover, because FVC would respond better to the improvement in the stenotic change after upper lobectomy in the non-COPD patients, FVC would not decrease due to the anatomic feature. This might explain why COPD may influence FVC only at earlyterm after upper lobectomy.
In this study, we demonstrated that COPD could strongly influence pulmonary function at both early-and late-terms after upper lobectomy, and that the site of lobectomy in non-COPD patients may strongly influence pulmonary function at both early-and late-terms after surgery. Although a large prospective study will be needed to confirm these findings, our results may be useful for improving the accuracy of predictions of postoperative pulmonary function and for preoperative counseling.
